NCT03024216 2021-05-26Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate CancerUniversity of HawaiiPhase 1 Completed37 enrolled